Masayoshi Suda

1.5k total citations · 1 hit paper
38 papers, 881 citations indexed

About

Masayoshi Suda is a scholar working on Physiology, Molecular Biology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Masayoshi Suda has authored 38 papers receiving a total of 881 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Physiology, 12 papers in Molecular Biology and 6 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Masayoshi Suda's work include Adipose Tissue and Metabolism (10 papers), Telomeres, Telomerase, and Senescence (9 papers) and Adipokines, Inflammation, and Metabolic Diseases (4 papers). Masayoshi Suda is often cited by papers focused on Adipose Tissue and Metabolism (10 papers), Telomeres, Telomerase, and Senescence (9 papers) and Adipokines, Inflammation, and Metabolic Diseases (4 papers). Masayoshi Suda collaborates with scholars based in Japan, United States and United Kingdom. Masayoshi Suda's co-authors include Tohru Minamino, Ippei Shimizu, Yohko Yoshida, Goro Katsuumi, Ryutaro Ikegami, Yoshitaka Hayashi, James L. Kirkland, Tamar Tchkonia, Tomoyoshi Soga and Yuka Hayashi and has published in prestigious journals such as Circulation, PLoS ONE and Circulation Research.

In The Last Decade

Masayoshi Suda

35 papers receiving 864 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

SGLT2 inhibition eliminates senescent cells and alleviates pathological aging

2024 67 citations Goro Katsuumi, Ippei Shimizu et al. Nature Aging profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Masayoshi Suda Japan	16	406	305	135	122	103	38	881
Goro Katsuumi Japan	13	271 0.7×	253 0.8×	121 0.9×	103 0.8×	73 0.7×	32	660
Karima Ait‐Aissa United States	18	384 0.9×	347 1.1×	319 2.4×	83 0.7×	104 1.0×	43	1.0k
Zhu‐Qin Zhang China	16	692 1.7×	377 1.2×	163 1.2×	160 1.3×	242 2.3×	29	1.5k
Weijian Hang China	17	363 0.9×	136 0.4×	236 1.7×	77 0.6×	115 1.1×	30	835
Ming-Hui Zou United States	11	423 1.0×	357 1.2×	185 1.4×	95 0.8×	178 1.7×	14	1.1k
Mary Y. K. Lee Hong Kong	11	253 0.6×	237 0.8×	63 0.5×	80 0.7×	136 1.3×	16	694
Longwei Xu China	13	369 0.9×	106 0.3×	141 1.0×	93 0.8×	127 1.2×	18	740
Panjamaporn Sangwung United States	18	750 1.8×	258 0.8×	124 0.9×	138 1.1×	234 2.3×	23	1.3k
Sankaranarayanan Kannan United States	13	792 2.0×	262 0.9×	127 0.9×	103 0.8×	57 0.6×	23	1.2k
Dongjin Wang China	13	463 1.1×	125 0.4×	109 0.8×	53 0.4×	116 1.1×	38	852

Countries citing papers authored by Masayoshi Suda

Since Specialization

Citations

This map shows the geographic impact of Masayoshi Suda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masayoshi Suda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masayoshi Suda more than expected).

Fields of papers citing papers by Masayoshi Suda

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masayoshi Suda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masayoshi Suda. The network helps show where Masayoshi Suda may publish in the future.

Co-authorship network of co-authors of Masayoshi Suda

This figure shows the co-authorship network connecting the top 25 collaborators of Masayoshi Suda. A scholar is included among the top collaborators of Masayoshi Suda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masayoshi Suda. Masayoshi Suda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Suda, Masayoshi, Maryam E. Rettmann, A. Deisher, et al.. (2025). Early and Late Myocardial Effects of Proton Beam Cardiac Radioablation. JACC. Clinical electrophysiology. 12(3). 552–563.

Katsuumi, Goro, Ippei Shimizu, Masayoshi Suda, et al.. (2024). SGLT2 inhibition eliminates senescent cells and alleviates pathological aging. Nature Aging. 4(7). 926–938. 67 indexed citations breakdown →

Suda, Masayoshi, Tamar Tchkonia, James L. Kirkland, & Tohru Minamino. (2024). Targeting senescent cells for the treatment of age-associated diseases. The Journal of Biochemistry. 177(3). 177–187. 7 indexed citations

Suda, Masayoshi, Goro Katsuumi, Tamar Tchkonia, James L. Kirkland, & Tohru Minamino. (2023). Potential Clinical Implications of Senotherapies for Cardiovascular Disease. Circulation Journal. 88(3). 277–284. 15 indexed citations

Suda, Masayoshi, Tohru Minamino, Jordan D. Miller, et al.. (2023). Senescent Cells: A Therapeutic Target in Cardiovascular Diseases. Cells. 12(9). 1296–1296. 64 indexed citations

Suda, Masayoshi, Ippei Shimizu, Goro Katsuumi, et al.. (2022). Glycoprotein nonmetastatic melanoma protein B regulates lysosomal integrity and lifespan of senescent cells. Scientific Reports. 12(1). 6522–6522. 45 indexed citations

Yoshida, Yohko, Ippei Shimizu, Masayoshi Suda, et al.. (2022). Differing impact of phosphoglycerate mutase 1-deficiency on brown and white adipose tissue. iScience. 25(5). 104268–104268. 2 indexed citations

Shimizu, Ippei, Yohko Yoshida, Goro Katsuumi, et al.. (2022). Endothelial SIRT-1 has a critical role in the maintenance of capillarization in brown adipose tissue. iScience. 25(11). 105424–105424. 8 indexed citations

Hayashi, Yuka, Ippei Shimizu, Yohko Yoshida, et al.. (2022). Coagulation factors promote brown adipose tissue dysfunction and abnormal systemic metabolism in obesity. iScience. 25(7). 104547–104547. 10 indexed citations

10.

Shimizu, Ippei, Yohko Yoshida, Ryutaro Ikegami, et al.. (2021). Cardiac mitofusin-1 is reduced in non-responding patients with idiopathic dilated cardiomyopathy. Scientific Reports. 11(1). 6722–6722. 22 indexed citations

11.

Shimizu, Ippei, Goro Katsuumi, Yohko Yoshida, et al.. (2021). Empagliflozin maintains capillarization and improves cardiac function in a murine model of left ventricular pressure overload. Scientific Reports. 11(1). 18384–18384. 29 indexed citations

12.

Suda, Masayoshi, Ippei Shimizu, Goro Katsuumi, et al.. (2020). Abstract 13736: Elimination of Senescent Cells Targeting Senescence Associated Glycoprotein (sagp) Improved the Atherosclerosis and Diabetes. Circulation. 142(Suppl_3). 1 indexed citations

13.

Shimizu, Ippei, Yohko Yoshida, Yuka Hayashi, et al.. (2019). Role of smooth muscle cell p53 in pulmonary arterial hypertension. PLoS ONE. 14(2). e0212889–e0212889. 32 indexed citations

14.

Yokoyama, Masataka, Ippei Shimizu, Ayako Nagasawa, et al.. (2019). p53 plays a crucial role in endothelial dysfunction associated with hyperglycemia and ischemia. Journal of Molecular and Cellular Cardiology. 129. 105–117. 44 indexed citations

15.

Yoshida, Yohko, Ippei Shimizu, Yoshitaka Hayashi, et al.. (2019). Peptide vaccine for semaphorin3E ameliorates systemic glucose intolerance in mice with dietary obesity. Scientific Reports. 9(1). 3858–3858. 8 indexed citations

16.

Shimizu, Ippei, Yohko Yoshida, Yuka Hayashi, et al.. (2018). Boysenberry polyphenol inhibits endothelial dysfunction and improves vascular health. PLoS ONE. 13(8). e0202051–e0202051. 44 indexed citations

17.

Ikegami, Ryutaro, Ippei Shimizu, Takeshi Sato, et al.. (2018). Gamma-Aminobutyric Acid Signaling in Brown Adipose Tissue Promotes Systemic Metabolic Derangement in Obesity. Cell Reports. 24(11). 2827–2837.e5. 41 indexed citations

18.

Suda, Masayoshi, Ippei Shimizu, Yohko Yoshida, et al.. (2017). Inhibition of dipeptidyl peptidase-4 ameliorates cardiac ischemia and systolic dysfunction by up-regulating the FGF-2/EGR-1 pathway. PLoS ONE. 12(8). e0182422–e0182422. 18 indexed citations

19.

Yoshida, Yohko, Ippei Shimizu, Goro Katsuumi, et al.. (2015). p53-Induced inflammation exacerbates cardiac dysfunction during pressure overload. Journal of Molecular and Cellular Cardiology. 85. 183–198. 61 indexed citations

20.

Suda, Masayoshi, Katsuhiko Hata, Yuka Nakamura, et al.. (2008). Peptides derived from repulsive guidance molecule act as antagonists. Biochemical and Biophysical Research Communications. 371(3). 501–504. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact